Seqens CDMO NA Identifies Key Trends Impacting Industry in 2021
December 21, 2020 09:15 ET
|
Seqens
Newburyport, MA, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active...
PCI Synthesis to Pick Up Four 2013 CMO Leadership Awards
March 10, 2014 09:17 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Mar 10, 2014) - PCI Synthesis, Inc. (www.pcisynthesis.com), a Boston-based Contract Manufacturing Organization (CMO) that manufactures new chemical entities (NCE),...
PCI Synthesis Announces 2014 Trends and Predictions
December 09, 2013 11:23 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwired - Dec 9, 2013) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
Golden State Law Group Alerts Public to NCES Student Loan Debt Study Revealing Problematic Trends
November 18, 2013 18:58 ET
|
Golden State Law Group
SAN DIEGO, CA--(Marketwired - Nov 18, 2013) - The San Diego bankruptcy attorneys at the Golden State Law Group have helped thousands of consumers and business clients work their way through...
PCI Employees Set New Records for Chemical Entities Under Development and Number of Employees
September 04, 2012 09:31 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Sep 4, 2012) - Bill Barrasso is doing his part to bring home the gold medal for his team, EZ-Flow, at PCI Synthesis, a 12-year-old custom chemical manufacturer of new...
Alexander Tretyakov Joins PCI as VP of Research and Development
May 30, 2012 11:05 ET
|
PCI Synthesis
NEWBURYPORT, MA--(Marketwire - May 30, 2012) - PCI Synthesis, Inc. (www.pcisynthesis.com), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...